NDC 52959-190 - Theraproxen-90
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-190
- Package NDCs from labels
- 52959-190-30
- Manufacturer
- Physician Therapeutics LLC | Amneal Pharmaceuticals | H.J. Harkins Company, Inc. | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Theraproxen-90 | Physician Therapeutics LLC | Amneal Pharmaceuticals | H.J. Harkins Company, Inc. | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Trepoxen-250 | Physician Therapeutics LLC | Amneal Pharmaceuticals | H.J. Harkins Company, Inc. | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Theraproxen | Physician Therapeutics LLC | Amneal Pharmaceuticals | Targeted Medical Pharma Inc. | H.J. Harkins Company, Inc | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-190-30 | Theraproxen-90 | 60 in 1 BOTTLE | TABLET | 60 | 250 mg | 14 |
| 52959-190-30 | Trepoxen-250 | 30 in 1 BOTTLE | TABLET | 30 | 250 mg | 13 |
| 52959-190-30 | Theraproxen | 30 in 1 BOTTLE | TABLET | 30 | 250 mg | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52959-190 | THERAPROXEN-90 (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC] | 14 | Unmatched | 20110812_29acd686-ca11-42b0-b5cd-5c1a04e45c29.zip |
| 52959-190 | TREPOXEN-250 (NAPROXEN,HISTIDINE) KIT [PHYSICIAN THERAPEUTICS LLC] | 13 | Unmatched | 20110812_c957df9a-eb66-432f-a280-9cd74389d667.zip |
| 52959-190 | THERAPROXEN (NAPROXEN, .GAMMA.-AMINOBUTYRIC ACID) KIT [PHYSICIAN THERAPEUTICS LLC] | 7 | Unmatched | 20110812_c3f47985-0027-4fa7-aab2-5bc6ca79a6e8.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Schuessler Tissue Salts Silica Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | f70dcf90-bde9-404d-9ede-4113553ccbff | 2025-08-04 | Warnings | ETJ7Z6XBU4 |
| Dolce and Gabbana Everlast Foundation SPF 20 02C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 09f9e59b-6f71-4d42-9b5d-275f756d985b | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Preferred Pharmaceuticals Inc | 470496f5-a71d-40b2-bf11-3a8d3d790962 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
| Neutrogena Mineral Ultra Sheer Face SPF 70 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 20e0badf-fe25-1d27-e063-6294a90a7cfe | 2025-07-28 | Warnings | 15FIX9V2JP |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 985a3341-0fe0-1dd6-e053-2a95a90ad2c5 | 2025-07-25 | Warnings | ETJ7Z6XBU4 |
| Dolce and Gabbana Everlast Foundation SPF 20 01N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 2ccf4e45-4cec-417d-9f4c-28f376025f1d | 2025-07-25 | Warnings | 15FIX9V2JP |
| SILICA MARINA | SILICON DIOXIDE | Boiron | 3aada26e-6a8e-f545-e063-6394a90a9f80 | 2025-07-24 | ETJ7Z6XBU4 | |
| Sunscreen | TITANIUM DIOXIDE 6.8% | Baxter of California, LLC | 146030bc-2bf4-25ea-e063-6294a90a4613 | 2025-07-24 | Warnings | 15FIX9V2JP |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1b4e96-c96f-6424-e053-2991aa0aef30 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| Cell Salts | CALC. FLUOR., CALC. PHOS., CALC.SULPH., FERRUM PHOSPHORICUM, KALI MUR., KALI PHOS., KALI SULPH., MAG. PHOS., NAT. MUR., NAT. PHOS., NAT.SULPHURICUM, SILICEA | Newton Laboratories, Inc. | 7a1a9ef9-9a54-5f94-e053-2a91aa0ab477 | 2025-07-24 | Warnings | ETJ7Z6XBU4 |
| La Defense Broad Spectrum SPF 30 Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Luzern Laboratories, Inc | 3f00befa-415d-415d-89e1-6ba8770ba51e | 2025-07-21 | Warnings | 15FIX9V2JP |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | PHOENIX RX LLC | 3a6637ca-0c55-f648-e063-6294a90aaef7 | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | ETJ7Z6XBU4 |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 29d98cf3-a0f2-3f89-e054-00144ff88e88 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | ANDA075927 57Y76R9ATQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.